HRC insider filings
Hill-Rom Holdings, Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2021-12-15. Screen HRC transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for HRC between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.
Recent insider filings — Hill-Rom Holdings, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2021-12-15 | 4 | Dodrill Amy M. — President - Surgical Solutions | Disposition to issuer (D): 3,903.07 · Disposition to issuer (D): 302 (derivative) @ $102.30 · Disposition to issuer (D): 1,032 (derivative) @ $77.84 · Disposition to issuer (D): 5,992 (derivative) @ $52.89 · Disposition to issuer (D): 9,513 (derivative) @ $61.86 · Disposition to issuer (D): 2,883 (derivative) · +4 more | EDGAR |
| 2021-12-15 | 4 | Moore Gregory J. — Director | Disposition to issuer (D): 1,520 (derivative) · Disposition to issuer (D): 1,870 (derivative) · Disposition to issuer (D): 1,798 (derivative) | EDGAR |
| 2021-12-15 | 4 | Ladone Mary Kay — SVP, Corp. Dev., Strat. & IR | Disposition to issuer (D): 2,284 · Disposition to issuer (D): 4,102 (derivative) @ $52.89 · Disposition to issuer (D): 6,054 (derivative) @ $61.86 · Disposition to issuer (D): 3,947 (derivative) · Disposition to issuer (D): 4,092 (derivative) · Disposition to issuer (D): 664 (derivative) · +2 more | EDGAR |
| 2021-12-15 | 4 | Norwood Felicia F — Director | Disposition to issuer (D): 1,870 (derivative) · Disposition to issuer (D): 1,798 (derivative) | EDGAR |
| 2021-12-15 | 4 | Bodem Barbara W. — SVP, Chief Financial Officer | Disposition to issuer (D): 14,039.76 · Disposition to issuer (D): 10,272 (derivative) @ $57.24 · Disposition to issuer (D): 15,491 (derivative) @ $52.89 · Disposition to issuer (D): 17,935 (derivative) @ $61.86 · Disposition to issuer (D): 7,452 (derivative) · Disposition to issuer (D): 9,091 (derivative) · +3 more | EDGAR |
| 2021-12-15 | 4 | Johnson Paul Sherwood — SVP & Pres. - PSS Acute Care | Disposition to issuer (D): 13,566 · Disposition to issuer (D): 2,409 (derivative) @ $77.84 · Disposition to issuer (D): 9,638 (derivative) @ $59.04 · Disposition to issuer (D): 14,787 (derivative) @ $52.89 · Disposition to issuer (D): 18,816 (derivative) @ $61.86 · Disposition to issuer (D): 7,113 (derivative) · +4 more | EDGAR |
| 2021-12-15 | 4 | Garrett Mary — Director | Disposition to issuer (D): 300 · Disposition to issuer (D): 2,762 (derivative) · Disposition to issuer (D): 2,184 (derivative) · Disposition to issuer (D): 1,762 (derivative) · Disposition to issuer (D): 1,870 (derivative) · Disposition to issuer (D): 1,798 (derivative) | EDGAR |
| 2021-12-15 | 4 | Groetelaars John P — Chief Executive Officer, Director | Disposition to issuer (D): 34,870 · Disposition to issuer (D): 39,962 (derivative) @ $66.92 · Disposition to issuer (D): 51,400 (derivative) @ $66.92 · Disposition to issuer (D): 42,314 (derivative) @ $59.04 · Disposition to issuer (D): 51,127 (derivative) @ $52.89 · Disposition to issuer (D): 59,783 (derivative) @ $61.86 · +5 more | EDGAR |
| 2021-12-15 | 4 | FRANK ANDREAS G — SVP, Pres. Front Line Care | Disposition to issuer (D): 16,539 · Disposition to issuer (D): 3,149 (derivative) @ $114.47 · Disposition to issuer (D): 10,040 (derivative) @ $111.07 · Disposition to issuer (D): 9,719 (derivative) @ $104.67 · Disposition to issuer (D): 10,215 (derivative) @ $102.30 · Disposition to issuer (D): 7,620 (derivative) @ $77.84 · +8 more | EDGAR |
| 2021-12-15 | 4 | Wagner Richard M — Corporate Controller | Disposition to issuer (D): 5,692.58 · Disposition to issuer (D): 706 (derivative) · Disposition to issuer (D): 1,634 (derivative) · Disposition to issuer (D): 1,343 (derivative) | EDGAR |
| 2021-12-15 | 4 | Kucheman William — Director | Disposition to issuer (D): 4,567 (derivative) · Disposition to issuer (D): 4,262 (derivative) · Disposition to issuer (D): 3,339 (derivative) · Disposition to issuer (D): 3,385 (derivative) · Disposition to issuer (D): 176 (derivative) · Disposition to issuer (D): 2,762 (derivative) · +4 more | EDGAR |
| 2021-12-15 | 4 | SCHLICHTING NANCY M — Director | Disposition to issuer (D): 2,762 (derivative) · Disposition to issuer (D): 2,184 (derivative) · Disposition to issuer (D): 1,762 (derivative) · Disposition to issuer (D): 1,870 (derivative) · Disposition to issuer (D): 1,798 (derivative) | EDGAR |
| 2021-12-15 | 4 | Rasin Deborah — SVP, Chief Legal Officer | Disposition to issuer (D): 26,527 · Disposition to issuer (D): 9,039 (derivative) @ $77.84 · Disposition to issuer (D): 8,573 (derivative) @ $59.04 · Disposition to issuer (D): 10,754 (derivative) @ $52.89 · Disposition to issuer (D): 12,783 (derivative) @ $61.86 · Disposition to issuer (D): 5,173 (derivative) · +4 more | EDGAR |
| 2021-12-15 | 4 | Enxing Seng Stacy — Director | Disposition to issuer (D): 3,339 (derivative) · Disposition to issuer (D): 3,385 (derivative) · Disposition to issuer (D): 176 (derivative) · Disposition to issuer (D): 2,762 (derivative) · Disposition to issuer (D): 2,184 (derivative) · Disposition to issuer (D): 1,762 (derivative) · +2 more | EDGAR |
| 2021-12-15 | 4 | Ellis Gary Lee — Director | Disposition to issuer (D): 1,024 (derivative) · Disposition to issuer (D): 2,184 (derivative) · Disposition to issuer (D): 1,762 (derivative) · Disposition to issuer (D): 1,870 (derivative) · Disposition to issuer (D): 1,798 (derivative) | EDGAR |
| 2021-12-15 | 4 | DEMPSEY WILLIAM G — Director | Disposition to issuer (D): 5,376 · Disposition to issuer (D): 4,262 (derivative) · Disposition to issuer (D): 3,339 (derivative) · Disposition to issuer (D): 3,385 (derivative) · Disposition to issuer (D): 176 (derivative) · Disposition to issuer (D): 2,762 (derivative) · +4 more | EDGAR |
| 2021-12-15 | 4 | GIERTZ JAMES R — Director | Disposition to issuer (D): 2,000 · Disposition to issuer (D): 959 (derivative) · Disposition to issuer (D): 2,865 (derivative) · Disposition to issuer (D): 3,498 (derivative) · Disposition to issuer (D): 3,992 (derivative) · Disposition to issuer (D): 4,567 (derivative) · +9 more | EDGAR |
| 2021-12-08 | 4 | Bodem Barbara W. — SVP, Chief Financial Officer | Option exercise (M): 992 · Tax withholding (F): 448 @ $155.73 · Option exercise (M): 2,640 · Tax withholding (F): 1,192 @ $155.73 · Gift (G): 2,000 @ $0 · Option exercise (M): 992 (derivative) @ $0 · +1 more | EDGAR |
| 2021-12-08 | 4 | FRANK ANDREAS G — SVP, Pres. Front Line Care | Gift (G): 5,300 @ $0 · Option exercise (M): 361 · Tax withholding (F): 192 @ $155.73 · Option exercise (M): 361 (derivative) @ $0 | EDGAR |
| 2021-11-17 | 4/A | Groetelaars John P — Chief Executive Officer, Director | Gift (G): 16,895 @ $0 | EDGAR |
| 2021-11-16 | 4 | Dodrill Amy M. — President - Surgical Solutions | Option exercise (M): 825 · Tax withholding (F): 242 @ $155.11 · Option exercise (M): 825 (derivative) @ $0 | EDGAR |
| 2021-11-16 | 4 | Ladone Mary Kay — SVP, Corp. Dev., Strat. & IR | Option exercise (M): 700 · Tax withholding (F): 253 @ $155.11 · Option exercise (M): 700 (derivative) @ $0 | EDGAR |
| 2021-11-16 | 4 | Bodem Barbara W. — SVP, Chief Financial Officer | Option exercise (M): 1,557 · Tax withholding (F): 699 @ $155.11 · Option exercise (M): 1,557 (derivative) @ $0 | EDGAR |
| 2021-11-16 | 4 | Johnson Paul Sherwood — SVP & Pres. - PSS Acute Care | Option exercise (M): 1,634 · Tax withholding (F): 724 @ $155.11 · Option exercise (M): 1,634 (derivative) @ $0 | EDGAR |
| 2021-11-16 | 4 | Groetelaars John P — Chief Executive Officer, Director | Option exercise (M): 5,193 · Tax withholding (F): 2,044 @ $155.11 · Option exercise (M): 5,193 (derivative) @ $0 | EDGAR |
| 2021-11-16 | 4 | FRANK ANDREAS G — SVP, Pres. Front Line Care | Option exercise (M): 1,115 · Tax withholding (F): 593 @ $155.11 · Option exercise (M): 1,115 (derivative) @ $0 | EDGAR |
| 2021-11-16 | 4 | Wagner Richard M — Corporate Controller | Option exercise (M): 840 · Tax withholding (F): 243 @ $155.11 · Option exercise (M): 840 (derivative) @ $0 | EDGAR |
| 2021-11-16 | 4 | Rasin Deborah — SVP, Chief Legal Officer | Option exercise (M): 1,109 · Tax withholding (F): 492 @ $155.11 · Option exercise (M): 1,109 (derivative) @ $0 | EDGAR |
| 2021-11-12 | 4 | Dodrill Amy M. — President - Surgical Solutions | Grant/award (A): 7,032 (derivative) @ $0 | EDGAR |
| 2021-11-12 | 4 | Ladone Mary Kay — SVP, Corp. Dev., Strat. & IR | Option exercise (M): 2,018 @ $94.14 · Sale (S): 2,018 @ $155.14 · Grant/award (A): 6,708 (derivative) @ $0 · Option exercise (M): 2,018 (derivative) @ $0 | EDGAR |
| 2021-11-12 | 4 | Bodem Barbara W. — SVP, Chief Financial Officer | Grant/award (A): 13,951 (derivative) @ $0 | EDGAR |
| 2021-11-12 | 4 | Johnson Paul Sherwood — SVP & Pres. - PSS Acute Care | Grant/award (A): 11,833 (derivative) @ $0 | EDGAR |
| 2021-11-12 | 4 | Groetelaars John P — Chief Executive Officer, Director | Grant/award (A): 46,502 (derivative) @ $0 | EDGAR |
| 2021-11-12 | 4 | FRANK ANDREAS G — SVP, Pres. Front Line Care | Grant/award (A): 8,796 (derivative) @ $0 | EDGAR |
| 2021-11-12 | 4 | Wagner Richard M — Corporate Controller | Grant/award (A): 1,343 (derivative) @ $0 | EDGAR |
| 2021-11-12 | 4 | Rasin Deborah — SVP, Chief Legal Officer | Grant/award (A): 8,878 (derivative) @ $0 | EDGAR |
| 2021-11-10 | 4 | Dodrill Amy M. — President - Surgical Solutions | Option exercise (M): 469 · Tax withholding (F): 141 @ $155.09 · Option exercise (M): 483 · Tax withholding (F): 168 @ $155.09 · Option exercise (M): 469 (derivative) @ $0 · Option exercise (M): 483 (derivative) @ $0 | EDGAR |
| 2021-11-10 | 4 | Ladone Mary Kay — SVP, Corp. Dev., Strat. & IR | Option exercise (M): 872 @ $78.16 · Sale (S): 872 @ $155.08 · Option exercise (M): 2,051 @ $103.11 · Sale (S): 2,051 @ $155.08 · Option exercise (M): 1,937 · Tax withholding (F): 568 @ $155.09 · +6 more | EDGAR |
| 2021-11-10 | 4 | Bodem Barbara W. — SVP, Chief Financial Officer | Option exercise (M): 1,249 · Tax withholding (F): 561 @ $155.09 · Option exercise (M): 1,249 (derivative) @ $0 | EDGAR |
| 2021-11-10 | 4 | Johnson Paul Sherwood — SVP & Pres. - PSS Acute Care | Option exercise (M): 938 · Tax withholding (F): 416 @ $155.09 · Option exercise (M): 1,193 · Tax withholding (F): 529 @ $155.09 · Option exercise (M): 938 (derivative) @ $0 · Option exercise (M): 1,193 (derivative) @ $0 | EDGAR |
| 2021-11-10 | 4 | Groetelaars John P — Chief Executive Officer, Director | Option exercise (M): 4,114 · Tax withholding (F): 1,712 @ $155.09 · Option exercise (M): 4,127 · Tax withholding (F): 1,722 @ $155.09 · Option exercise (M): 4,114 (derivative) @ $0 · Option exercise (M): 4,127 (derivative) @ $0 | EDGAR |
| 2021-11-10 | 4 | FRANK ANDREAS G — SVP, Pres. Front Line Care | Option exercise (M): 644 · Tax withholding (F): 343 @ $155.09 · Option exercise (M): 789 · Tax withholding (F): 330 @ $155.09 · Option exercise (M): 644 (derivative) @ $0 · Option exercise (M): 789 (derivative) @ $0 | EDGAR |
| 2021-11-10 | 4 | Wagner Richard M — Corporate Controller | Option exercise (M): 740 · Tax withholding (F): 215 @ $155.09 · Option exercise (M): 704 · Tax withholding (F): 204 @ $155.09 · Option exercise (M): 740 (derivative) @ $0 · Option exercise (M): 704 (derivative) @ $0 | EDGAR |
| 2021-11-10 | 4 | Rasin Deborah — SVP, Chief Legal Officer | Option exercise (M): 835 · Tax withholding (F): 370 @ $155.09 · Option exercise (M): 868 · Tax withholding (F): 385 @ $155.09 · Option exercise (M): 835 (derivative) @ $0 · Option exercise (M): 868 (derivative) @ $0 | EDGAR |
| 2021-11-03 | 4 | Bodem Barbara W. — SVP, Chief Financial Officer | Grant/award (A): 9,017 @ $0 · Tax withholding (F): 3,102 @ $155.17 | EDGAR |
| 2021-11-03 | 4 | Johnson Paul Sherwood — SVP & Pres. - PSS Acute Care | Grant/award (A): 8,537 @ $0 · Tax withholding (F): 3,288 @ $155.17 | EDGAR |
| 2021-11-03 | 4 | Groetelaars John P — Chief Executive Officer, Director | Grant/award (A): 37,476 @ $0 · Tax withholding (F): 15,593 @ $155.17 | EDGAR |
| 2021-11-03 | 4 | FRANK ANDREAS G — SVP, Pres. Front Line Care | Grant/award (A): 5,848 @ $0 · Tax withholding (F): 2,230 @ $155.17 | EDGAR |
| 2021-11-03 | 4 | Rasin Deborah — SVP, Chief Legal Officer | Grant/award (A): 7,593 @ $0 · Tax withholding (F): 2,575 @ $155.17 | EDGAR |
| 2021-07-30 | 4 | Ladone Mary Kay — SVP, Corp. Dev., Strat. & IR | Sale (S): 3,000 @ $125 · Sale (S): 2,698 @ $130 · Option exercise (M): 1,307 @ $78.16 · Sale (S): 1,307 @ $125 · Option exercise (M): 2,051 @ $103.11 · Sale (S): 2,051 @ $130 · +2 more | EDGAR |
Recent 8-K events — Hill-Rom Holdings, Inc.
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2021-12-13 | 8-K | 1.02 — Termination of a Material Definitive Agreement 2.01 — Completion of Acquisition or Disposition of Assets 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 3.03 — Material Modification to Rights of Security Holders 5.01 — Changes in Control of Registrant 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2021-12-03 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2021-11-23 | 8-K | 8.01 — Other Events | EDGAR |
| 2021-11-08 | 8-K/A | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2021-11-05 | 8-K | 2.02 — Results of Operations and Financial Condition 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2021-09-02 | 8-K | 1.01 — Entry into a Material Definitive Agreement 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2021-08-06 | 8-K | 2.01 — Completion of Acquisition or Disposition of Assets 9.01 — Financial Statements and Exhibits | EDGAR |
| 2021-07-30 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2021-04-30 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2021-04-29 | 8-K | 1.01 — Entry into a Material Definitive Agreement | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=HRC returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs